Return to:
Aids ArticlesOr:
Recent Aids Articleshttp://www.cnbc.com/id/21368702CNBC - Gilead Sciences posted a third-quarter profit that topped Wall Street targets on Thursday, on sales of drugs that fight the virus that causes AIDS, compared with a year-ago net loss due to acquisition-related costs. [ MRK Loading ...
Article Finder:
October 18, 2007 04:09:00 PM